93 related articles for article (PubMed ID: 24030996)
1. Immunology. Bound for glory.
Cohen J
Science; 2013 Sep; 341(6151):1168-71. PubMed ID: 24030996
[No Abstract] [Full Text] [Related]
2. AIDS vaccines: back to 'plan A'.
Check E
Nature; 2003 Jun; 423(6943):912-4. PubMed ID: 12827164
[No Abstract] [Full Text] [Related]
3. HIV vaccine design and the neutralizing antibody problem.
Burton DR; Desrosiers RC; Doms RW; Koff WC; Kwong PD; Moore JP; Nabel GJ; Sodroski J; Wilson IA; Wyatt RT
Nat Immunol; 2004 Mar; 5(3):233-6. PubMed ID: 14985706
[No Abstract] [Full Text] [Related]
4. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope.
Emini EA; Koff WC
Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131
[No Abstract] [Full Text] [Related]
5. B cell antigenic site mapping of HIV-1 glycoproteins.
Neurath AR
Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
[No Abstract] [Full Text] [Related]
6. Structural biology: images from the surface of HIV.
Burton DR
Nature; 2006 Jun; 441(7095):817-8. PubMed ID: 16778874
[No Abstract] [Full Text] [Related]
7. Immunology. Close to the edge: neutralizing the HIV-1 envelope.
Nabel GJ
Science; 2005 Jun; 308(5730):1878-9. PubMed ID: 15976295
[No Abstract] [Full Text] [Related]
8. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing antibodies and antigens in AIDS.
Norley SG; Kurth R
Infection; 1991; 19 Suppl 2():S83-8. PubMed ID: 1707855
[TBL] [Abstract][Full Text] [Related]
10. AIDS/HIV. A boost for HIV vaccine design.
Burton DR; Weiss RA
Science; 2010 Aug; 329(5993):770-3. PubMed ID: 20705840
[No Abstract] [Full Text] [Related]
11. The antigenic structure of the HIV gp120 envelope glycoprotein.
Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
[TBL] [Abstract][Full Text] [Related]
12. Population-based analysis of HIV-1 antibodies reveals structural constraints that may inform vaccine design.
Tobin SC
AIDS; 2015 Sep; 29(15):N13. PubMed ID: 26237101
[No Abstract] [Full Text] [Related]
13. [Immunochemical homology of HIV-1 envelope proteins and human apolipoprotein AI].
Panin LE; Kostina NE; Poteriaeva ON; Fediuk NV
Vopr Virusol; 2001; 46(5):13-6. PubMed ID: 11715702
[TBL] [Abstract][Full Text] [Related]
14. [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
Sorice F; Vullo V; Cirelli A; Catania S; Mastroianni CM; Contini C; Delia S
Boll Ist Sieroter Milan; 1989; 68(2):115-21. PubMed ID: 2562362
[TBL] [Abstract][Full Text] [Related]
15. Public health. AIDS vaccine still alive as booster after second failure in Thailand.
Cohen J
Science; 2003 Nov; 302(5649):1309-10. PubMed ID: 14631004
[No Abstract] [Full Text] [Related]
16. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.
Dis Markers; 1991; 9(1):51. PubMed ID: 1742945
[No Abstract] [Full Text] [Related]
17. [Diagnostic value of antibodies against HIV-1 proteins in seropositive drug addicts tested by the western blotting method].
Swiderska H; Kalinowska B
Przegl Epidemiol; 1992; 46(1-2):19-25. PubMed ID: 1475386
[TBL] [Abstract][Full Text] [Related]
18. Structural biology. Is high-tech view of HIV too good to be true?
Cohen J
Science; 2013 Aug; 341(6145):443-4. PubMed ID: 23908196
[No Abstract] [Full Text] [Related]
19. Immunology in AIDS in 1990.
Sela M
AIDS; 1990; 4 Suppl 1():S9-14. PubMed ID: 1983804
[No Abstract] [Full Text] [Related]
20. Genotypic and phenotypic variation of HIV-1: impact on AIDS pathogenesis and vaccination.
Wolfs TF; Nara PL; Goudsmit J
Chem Immunol; 1993; 56():1-33. PubMed ID: 8383980
[No Abstract] [Full Text] [Related]
[Next] [New Search]